Staropoli, N.; Arbitrio, M.; Salvino, A.; Scionti, F.; Ciliberto, D.; Ingargiola, R.; Labanca, C.; Agapito, G.; Iuliano, E.; Barbieri, V.;
et al. A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics. Biomedicines 2022, 10, 1210.
https://doi.org/10.3390/biomedicines10051210
AMA Style
Staropoli N, Arbitrio M, Salvino A, Scionti F, Ciliberto D, Ingargiola R, Labanca C, Agapito G, Iuliano E, Barbieri V,
et al. A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics. Biomedicines. 2022; 10(5):1210.
https://doi.org/10.3390/biomedicines10051210
Chicago/Turabian Style
Staropoli, Nicoletta, Mariamena Arbitrio, Angela Salvino, Francesca Scionti, Domenico Ciliberto, Rossana Ingargiola, Caterina Labanca, Giuseppe Agapito, Eleonora Iuliano, Vito Barbieri,
and et al. 2022. "A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics" Biomedicines 10, no. 5: 1210.
https://doi.org/10.3390/biomedicines10051210
APA Style
Staropoli, N., Arbitrio, M., Salvino, A., Scionti, F., Ciliberto, D., Ingargiola, R., Labanca, C., Agapito, G., Iuliano, E., Barbieri, V., Cucè, M., Zuccalà , V., Cannataro, M., Tassone, P., & Tagliaferri, P.
(2022). A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics. Biomedicines, 10(5), 1210.
https://doi.org/10.3390/biomedicines10051210
